$ICPT INTERCEPT PHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in INTERCEPT PHARMACEUTICALS, INC. for free.

CIK Number: 0001270073
IRS Number: 223868459
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ICPT
Company Address: 10 HUDSON YARDS, 37TH FLOOR NEW YORK 10001
Phone number: 646-747-1000
Former name: INTERCEPT PHARMACEUTICALS INC, date of change: 2003-11-13

Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.

Market Capitalization: $2.80B
Prev close: $113.57
Average Daily Volume: 475,158
Days Low: $110.70
Year Low: $89.76
Year High: $177.93

INTERCEPT PHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 01 2021ICPTINTERCEPT PHARMACE ...BRADBURY DANIELDirectorOption ExerciseA17.0812,089206,48012,089
Jun 01 2021ICPTINTERCEPT PHARMACE ...BRADBURY DANIELDirectorGrantA0.007,029015,8118.8 K to 15.8 K (+80.04 %)
Jun 01 2021ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorOption ExerciseA17.0812,089206,48012,089
Jun 01 2021ICPTINTERCEPT PHARMACE ...SBLENDORIO GLENNDirectorGrantA0.007,029015,7108.7 K to 15.7 K (+80.97 %)
May 13 2021ICPTINTERCEPT PHARMACE ...Cawkwell GailSVP, Med Affairs, S ...Payment of ExerciseF17.753195,66232,55332.9 K to 32.6 K (-0.97 %)
May 11 2021ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF17.151282,19523,71123.8 K to 23.7 K (-0.54 %)
May 04 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorPayment of ExerciseF19.783,81775,500502,649506.5 K to 502.6 K (-0.75 %)
May 04 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorGrantA19.786,138121,410506,466500.3 K to 506.5 K (+1.23 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Weyer ChristianEVP, Research & Dev ...Payment of ExerciseF24.28461,11727,34127.4 K to 27.3 K (-0.17 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Venezia RoccoChief Accounting Of ...Payment of ExerciseF24.282970414,28914.3 K to 14.3 K (-0.20 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Ford David AChief Human Resourc ...Payment of ExerciseF24.28922,23423,83923.9 K to 23.8 K (-0.38 %)
Apr 05 2021ICPTINTERCEPT PHARMACE ...Durso Jerome BenedictPresident & CEOPayment of ExerciseF24.282897,01782,14282.4 K to 82.1 K (-0.35 %)
Apr 01 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorPayment of ExerciseF23.083,65884,427500,328504 K to 500.3 K (-0.73 %)
Apr 01 2021ICPTINTERCEPT PHARMACE ...Pruzanski MarkDirectorGrantA23.086,136141,619503,986497.9 K to 504 K (+1.23 %)
Mar 12 2021ICPTINTERCEPT PHARMACE ...AKKARAJU SRINIVASDirectorBuyP21.29147,0003,129,630640,688493.7 K to 640.7 K (+29.78 %)

View all INTERCEPT PHARMACEUTICALS, INC. insider transactions.